Research programme: membrane lipid modulators - Lipopharma

Drug Profile

Research programme: membrane lipid modulators - Lipopharma

Alternative Names: LP-1810; LP-181T1; LP-182A1; LP-183A1; LP-183A2; LP-204A1; LP-205A1; LP-226A1

Latest Information Update: 16 Jul 2016

Price : $50

At a glance

  • Originator Lipopharma
  • Class Fatty acids
  • Mechanism of Action Membrane lipid modulators
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • No development reported Cancer; Cardiovascular disorders; Inflammation; Lipid metabolism disorders; Neurodegenerative disorders

Most Recent Events

  • 16 Jul 2016 No recent reports of development identified for preclinical development in Lipid-metabolism-disorders in Spain
  • 16 Jul 2016 No recent reports of development identified for research development in Cancer in Spain
  • 16 Jul 2016 No recent reports of development identified for research development in Cardiovascular-disorders in Spain
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top